Suprax recalls
The FDA has published 2 recalls involving Suprax since 2014. The latest was reported on 9 Apr 2014. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 9 Apr 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 2 100%
Why suprax is recalled
Companies
By year
All suprax recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Suprax, Cefixime for Oral Suspension USP 500 mg recalled | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Suprax, Cefixime for Oral Suspension USP, 500 mg recalled | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Suprax?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.